Therefore, in order to verify the involvement of EGF and ErbB2 receptors in vp17s clonogenic activity independently of EBV protein expression, we also tested the inhibition of vp17-triggered cell proliferation by AG1478 and AG879 in the EBV-negative BJAB human lymphoma B-cell line. The gene discussed is EGF; the disease is lymphoma.